Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo-controlled, Multi-center Phase II Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral AFA-281 in Patients With Painful Lumbosacral Radiculopathy

NCT06649747 is registered in ClinicalTrials.gov with Afasci Inc as lead sponsor.

NCT NCT06649747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo-controlled, Multi-center Phase II Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral AFA-281 in Patients With Painful Lumbosacral Radiculopathy
Lead sponsor
Afasci Inc
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2027
Completion date
March 31, 2032
Enrollment
408 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lumbosacral radiculopathy